Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The in situ induction of tumoricidal activity in alveolar macrophages by liposomes containing muramyl dipeptide is a thymus-independent process.

× No keyword cloud information.

12 in total

1. Induction of tumouricidal leucocytes by the intranasal application of MTP-PE, a lipophilic muramyl peptide.

Authors: A F Brownbill; D G Braun; P Dukor; G Schumann
Journal: Cancer Immunol Immunother Date: 1985 Impact factor: 6.968

Review 2. Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease.

Authors: I J Fidler; G Poste
Journal: Springer Semin Immunopathol Date: 1982

Review 3. Therapy of disseminated melanoma by liposome-activated macrophages.

Authors: I J Fidler
Journal: World J Surg Date: 1992 Mar-Apr Impact factor: 3.352

Review 4. Macrophages and cancer.

Authors: P W Whitworth; C C Pak; J Esgro; E S Kleinerman; I J Fidler
Journal: Cancer Metastasis Rev Date: 1990-02 Impact factor: 9.264

5. Mechanism(s) of in vitro macrophage activation with Nocardia rubra cell wall skeleton: the effects on macrophage activating factor production by lymphocytes.

Authors: T Masuno; S Hayashi; M Ito; T Ikeda; T Ogura; S Kishimoto; Y Yamamura
Journal: Cancer Immunol Immunother Date: 1986 Impact factor: 6.968

6. Systemic activation of macrophages by liposome-entrapped muramyl tripeptide in mice pretreated with the chemotherapeutic agent adriamycin.

Authors: G Hisano; I J Fidler
Journal: Cancer Immunol Immunother Date: 1982 Impact factor: 6.968

7. In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362.

Authors: T Utsugi; C P Dinney; J J Killion; I J Fidler
Journal: Cancer Immunol Immunother Date: 1991 Impact factor: 6.968

8. Comparative efficacy of liposomes containing synthetic bacterial cell wall analogues for tumoricidal activation of monocytes and macrophages.

Authors: T Utsugi; A Nii; D Fan; C C Pak; Y Denkins; P van Hoogevest; I J Fidler
Journal: Cancer Immunol Immunother Date: 1991 Impact factor: 6.968

9. Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2.

Authors: S R Zhang; R R Salup; P E Urias; T A Twilley; J E Talmadge; R B Herberman; R H Wiltrout
Journal: Cancer Immunol Immunother Date: 1986 Impact factor: 6.968

Review 10. Macrophages in cancer metastases and their relevance to metastatic growth.

Authors: M E Key
Journal: Cancer Metastasis Rev Date: 1983 Impact factor: 9.264